Skip to content
healthcare.dev

COLESTIPOL HYDROCHLORIDE

NDC 0115-5213, COLESTIPOL HYDROCHLORIDE, suspension, from Amneal Pharmaceuticals of New York LLC.

Product NDC
0115-5213
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077277
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0115-5213 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • COLESTIPOL HYDROCHLORIDE5 g/1

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
0115-5213-0200115521302100 SUSPENSION in 1 BOTTLE (0115-5213-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/839354bd-cbac-4d18-8c02-b1b93766af38

Use it

Look up 0115-5213 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0115-5213 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0115-5213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.